Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomized controlled trial. [Diabetes : Treatment Satisfaction]
The Lancet, 371 (9618), 1073-1084. View article here.
Improving treatment satisfaction and other patient-reported outcomes in people with Type 2 diabetes: the role of once-daily insulin glargine. [Diabetes : Treatment Satisfaction]
Diabetes, Obesity and Metabolism 10 (Suppl.2), 50-65. View article here.
Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes. [Diabetes : Quality of Life]
Diabetes Care 31 (6) 1112-7. View article here.
The Dose Adjustment For Normal Eating (DAFNE) Trial: improvements in HbA1c still apparent and quality of life benefits well maintained at 4-year follow-up. [Diabetes : Quality of Life]
Arousal thresholds in dreaming sleep.
Physiological Psychology, 2: (2) 109-110.
Stress and health [Generic]
In T Cox (Ed) Stress. London: Macmillan, pp91-111.
A critique of Totman’s thesis of the “social” causes of illness. New Forum. [Generic]
The Journal of Psychology and Psychotherapy Association, p13.
Psychophysiological effects of stressful experiences and the management of diabetes mellitus. [Diabetes]
In DJ Oborne, MM Gruneberg and JR Eiser (Eds) Research in Psychology and Medicine. London: Academic Press, pp133-139.
Autofeedback in the management of diabetes mellitus. [Diabetes]
Biological Psychology, 11, 277.
Life events and the control of diabetes mellitus. [Diabetes]
Journal of Psychosomatic Research, 23, 159-162. View article here .
© 2015 Health Psychology Research Ltd. Company no. 4803452
Website by NDP Studio